Skip to main content
. Author manuscript; available in PMC: 2012 Sep 1.
Published in final edited form as: Am J Addict. 2011 Jul 18;20(5):397–404. doi: 10.1111/j.1521-0391.2011.00153.x

Table 2.

Buprenorphine Dosing

Phase 1 (n=14) Phase 2 (n=13) Phase 3 (n=14) P value
Initial buprenorphine* dose 2 (1) 3 (1) 3 (1) <.05 (1<2,3)
Total buprenorphine* dose at the program 9 (6) 7 (3) 6 (4) NS
Total buprenorphine* dose, Day #1 13 (6) 11 (6) 14 (9) NS
*

Includes mean (standard deviation) buprenorphine dose in mg for both buprenorphine-naloxone combination and pure buprenorphine formulations.

NS = non-significant